DCTH 241220 10.00C (DCTH241220C10000) Stock Options, News & Quotes

0.45
-0.10-18.18%

15min DelayClose Nov 22 16:00 ET

0.62High0.45Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

bro why so serious

Nov 14 06:20

$Delcath Systems (DCTH.US)$ why always fall

Jaguar8

Aug 27 07:31

NEWS

$Delcath Systems (DCTH.US)$
Delcath Systems, Inc. Announces Positive Outcomes from Independent Study on Hepatic Perfusion for Uveal Melanoma Patients
Delcath Systems, Inc. (Nasdaq: DCTH) announced positive outcomes from an independent study on hepatic perfusion for uveal melanoma patients. The study, conducted by researchers at Moffitt Cancer Center, compared Delcath's HEPZATO KIT™ to immunotherapy and other liver-directed therapies. Key findings include:
1. Overall Survival (OS): Median OS ...

Trytosaveabit

Aug 26 15:03

Update

$Delcath Systems (DCTH.US)$ Reuters· 1 min ago1min
Delcath Systems, Inc. Announces Promising Results From Independent Study on Repeated Hepatic Chemosaturation for Liver Tumors

Jaguar8

Aug 26 15:01

NEWS

$Delcath Systems (DCTH.US)$
Delcath Systems, Inc. Announces Promising Results from Independent Study on Repeated Hepatic Chemosaturation for Liver Tumors
Delcath Systems (Nasdaq: DCTH) announced promising results from an independent study on its CHEMOSAT® Hepatic Delivery System for liver tumors. The study, conducted at the University Hospital of Leipzig, Germany, evaluated 33 patients with various cancers, including uveal melanoma and cholangiocarcinoma. Key findings include:
- A 91% diseas...

Trytosaveabit

May 14 12:50

Nice earnings pump!

$Delcath Systems (DCTH.US)$